Search Results - "Bakrin, N."

Combining HIPEC to Interval Surgery in Ovarian Cancer? One Step Forward with a Second Randomized Study: Comment on “Cytoreductive Surgery with or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer—A Phase 3 Clinical Trial” by Noiret, B., Bakrin, N., Eveno, C.

Get full text

Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with Cisplatin by Laplace, N., Kepenekian, V., Friggeri, A., Vassal, O., Ranchon, F., Rioufol, C., Gertych, W., Villeneuve, L., Glehen, O., Bakrin, N.

“…Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to provide benefits in the management of peritoneal…”
Get full text

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Persistent and Recurrent Advanced Ovarian Carcinoma: A Multicenter, Prospective Study of 246 Patients by Bakrin, N., Cotte, E., Golfier, F., Gilly, F. N., Freyer, G., Helm, W., Glehen, O., Bereder, J. M.

“…Background Epithelial ovarian carcinoma is the main cause of death from gynaecological cancers in the western world. The initial response rate to the frontline…”
Get full text

Occupational exposure to platinum drugs during intraperitoneal chemotherapy. Biomonitoring and surface contamination by Ndaw, S., Hanser, O., Kenepekian, V., Vidal, M., Melczer, M., Remy, A., Robert, A., Bakrin, N.

“…•Exposure of the surgical team during intraperitoneal chemotherapy was investigated.•Low urinary platinum levels from the surgical team were reported.•Urinary…”
Get full text

Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: A French multicentre retrospective cohort study of 566 patients by Bakrin, N, Bereder, J.M, Decullier, E, Classe, J.M, Msika, S, Lorimier, G, Abboud, K, Meeus, P, Ferron, G, Quenet, F, Marchal, F, Gouy, S, Morice, P, Pomel, C, Pocard, M, Guyon, F, Porcheron, J, Glehen, O

“…Abstract Background Despite a high response rate to front-line therapy, prognosis of epithelial ovarian carcinoma (EOC) remains poor. Approaches that combine…”
Get full text

Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies by Passot, G, Bakrin, N, Isaac, S, Decullier, E, Gilly, F.N, Glehen, O, Cotte, E

“…Abstract Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are considered the only curative treatment for many…”
Get full text

Troponin measurement for risk stratification after cytoreductive surgery by Vacheron, C-H, Lambert, A, Fauvernier, M, Vassal, O, Wallet, F, Bakrin, N, Vaudoyer, D, Kepenekian, V, Passot, G, Glehen, O, Piriou, V, Friggeri, A

“…Several studies have raised interest in the use of postoperative troponin levels to stratify risk of postoperative morbidity and mortality. In this study,…”
Get full text

Malignant epithelial ovarian cancer: Role of intra peritoneal chemotherapy and hyperthermic intra peritoneal chemotherapy (HIPEC): Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa by Bakrin, N, Gladieff, L

“…Intraperitoneal drug delivery in first-line treatment of advanced ovarian cancer have been widely studied. After a complete primary surgery or with residual…”
Get full text

Response to: “Hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer should be proposed in eight time points” by Glehen, O, Bakrin, N

Get full text

Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A prospective study of 216 patients by Passot, G, Bakrin, N, Roux, A.S, Vaudoyer, D, Gilly, F.-N, Glehen, O, Cotte, E

“…Abstract Introduction Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) have demonstrated promising results in the treatment of…”
Get full text

Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer by Bakrin, N, Classe, J.M, Pomel, C, Gouy, S, Chene, G, Glehen, O

“…Summary Ovarian cancer remains the fourth leading cause of cancer death in women in France. It is all too often diagnosed at an advanced stage with peritoneal…”
Get full text

Pressurized IntraPeritoneal Aerosole Chemotherapy (PIPAC) for unresectable peritoneal carcinomatosis: The French experience by Sgarbura, O.A, Alyami, M, Passot, G, Bakrin, N, Gagniere, J, Villeneuve, L, Quénet, F, Glehen, O

Get full text

Glisson capsulectomy for extensive superficial liver involvement in peritoneal carcinomatosis (with video) by Dagbert, F, Passot, G, Glehen, O, Bakrin, N

Get full text

Colorectal resection with pelvic peritoneal carcinomatosis en-bloc resection in a male patient (with video) by Dagbert, F, Bakrin, N, Glehen, O, Passot, G

Get full text

Intraperitoneal vascular endothelial growth factor burden in peritoneal surface malignancies treated with curative intent: The first step before intraperitoneal anti-vascular endothelial growth factor treatment? by Passot, G, Bakrin, N, Garnier, L, Roux, A, Vaudoyer, D, Wallet, F, Gilly, F.N, Glehen, O, Cotte, E

“…Abstract Introduction Vascular endothelial growth factor (VEGF) is one of the most important angiogenic factors in solid tumours and plays an important role in…”
Get full text

Primary peritoneal serous carcinoma treated by cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. A multi-institutional study of 36 patients by Bakrin, N, Gilly, F.N, Baratti, D, Bereder, J.M, Quenet, F, Lorimier, G, Mohamed, F, Elias, D, Glehen, O

“…Abstract Aim Primary peritoneal serous carcinoma (PPSC) is a rare condition, histologically identical to ovarian serous carcinoma and often diagnosed at late…”
Get full text

CHIP and ovarian cancer by Lécuru, F, Bakrin, N, Classe, J M, Colombo, P E, Ferron, G, Freyer, G, Glehen, O, Gouy, S, Huchon, C, Narducci, F, Pocard, M, Pomel, C, Rouzier, R

Get full text

Partie 2 rédigée à partir de la synthèse de la recommandation nationale de bonnes pratiques cliniques intitulée « Conduites à tenir initiales devant des patientes atteintes d’un cancer épithélial de l’ovaire » élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY et labélisée par l’INCa. (Traitement systémique et intrapéritonéal, personnes âgées, préservation de la fertilité et suivi) by Lavoué, V., Huchon, C., Akladios, C., Alfonsi, P., Bakrin, N., Ballester, M., Bendifallah, S., Bolze, P.A., Bonnet, F., Bourgin, C., Chabbert-Buffet, N., Collinet, P., Courbiere, B., De la Motte Rouge, T., Devouassoux-Shisheboran, M., Falandry, C., Ferron, G., Fournier, L., Gladieff, L., Golfier, F., Gouy, S., Guyon, F., Lambaudie, E., Leary, A., Lécuru, F., Lefrère-Belda, M.A., Leblanc, E., Lemoine, A., Narducci, F., Ouldamer, L., Pautier, P., Planchamp, F., Pouget, N., Ray-Coquard, I., Rousset-Jablonski, C., Sénéchal-Davin, C., Touboul, C., Thomassin-Naggara, I., Uzan, C., You, B., Daraï, E.

“…Adjuvant chemotherapy with carboplatin and paclitaxel is recommended for all high-grade ovarian or Fallopian tube cancers, stage FIGO I-IIA (grade A). After a…”
Get full text

Advances in the management of peritoneal malignancies by Kepenekian, Vahan, Bhatt, Aditi, Péron, Julien, Alyami, Mohammad, Benzerdjeb, Nazim, Bakrin, Naoual, Falandry, Claire, Passot, Guillaume, Rousset, Pascal, Glehen, Olivier

“…Peritoneal surface malignancies (PSMs) are usually associated with a poor prognosis. Nonetheless, in line with advances in the management of most…”
Get full text

614P Tolerance and preliminary efficacy of intraperitoneal (IP) nivolumab after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with advanced ovarian carcinoma: A phase I study with expansion cohort (ICONIC) by Corbaux, P., You, B., Kepenekian, V., Bakrin, N., Gelot, A., Dayde, D., Sajous, C., Lamuraglia, M., Peron, J., Glehen, O., Freyer, G.

Get full text